Learn about SPRAVATO® (esketamine) CIII nasal spray, a prescription medicine for two indications. See full Prescribing & Safety Info, including BOXED WARNINGS.

SPRAVATO® is a prescription medicine, used along with an antidepressant taken by mouth to treat: • Adults with treatment-resistant depression (TRD) SPRAVATO® is not for use as a medicine to prevent or relieve pain (anesthetic). It is not known if SPRAVATO® is safe or effective as an anesthetic medicine.

SPRAVATO® is a non-competitive N-methyl D-aspartate (NMDA) receptor antagonist indicated, in conjunction with an oral antidepressant, for the treatment of: • Treatment-resistant depression (TRD) in adults.

By getting a SPRAVATO withMe Observation Rebate Program benefit, you confirm that you have read, understood, and agree to the program requirements on this page. You need to submit a rebate request with proof of provider payment to get payment under the SPRAVATO withMe Observation Rebate Program.

SPRAVATO® is a prescription medicine, used along with an antidepressant taken by mouth to treat: • Adults with treatment-resistant depression (TRD) • Depressive symptoms in adults with major depressive disorder (MDD) with suicidal thoughts or actions

SPRAVATO

SPRAVATO® is a prescription medicine, used along with an antidepressant taken by mouth to treat: • Adults with treatment-resistant depression (TRD) • Depressive symptoms in adults with major depressive disorder (MDD) with suicidal thoughts or actions

You must be enrolled in the SPRAVATO withMe Savings Program before your treatment date in order to receive a rebate for your SPRAVATO® medication. You can enroll online at MyJanssenCarePath.com/express or by calling 844-4S-WITHME (844-479-4846).

You must be enrolled in the SPRAVATO withMe Savings Program before your treatment date in order to receive a rebate for your SPRAVATO® medication. You can enroll online at SPRAVATOwithMePatientAuth.com or by calling 844-4S-WITHME (844-479-4846).